NCT03601858

Brief Summary

The main objective of this study is to carry out a descriptive study of the clinical and demographic characteristics of patients having consulted for a specialized opinion about ADHD in adults of the psychiatric service of the Strasbourg University Hospital. The characteristics of patients were collected during the first consultation, by the psychiatrist, and analyzed retrospectively. The secondary objective is to evaluate the evolution at one year in terms of follow-up, maintenance under medical treatment and perceived effects of it. The patients who had a prescription for pharmacological treatment of ADHD were contacted between 9 and 15 months after the first consultation and responded to a questionnaire assessing the evolution.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2018

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 3, 2018

Completed
23 days until next milestone

First Posted

Study publicly available on registry

July 26, 2018

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2019

Completed
Last Updated

July 26, 2018

Status Verified

June 1, 2018

Enrollment Period

1 year

First QC Date

July 3, 2018

Last Update Submit

July 17, 2018

Conditions

Attention Deficit and Hyperactivity Disorder

Keywords

Attention deficithyperactivity disorderAdultEpidemiologyEvolutiontreatment

Outcome Measures

Primary Outcomes (1)

  • Hyperactivity Disorder

    Measuring from the medical files of patients and questionnaire

    Between 9 and 15 months after the first consultation, contact of patients and collection of data for the evolution at one year analyze

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patient Having a specialized consultation about ADHD in adults in the psychiatric service of the Strasbourg University Hospital

You may qualify if:

  • Age \> 18
  • Having a specialized consultation about ADHD in adults in the psychiatric service of the Strasbourg University Hospital
  • Agree with the use of medical files from the consultation for medical research

You may not qualify if:

  • Disgree with the use of medical files from the consultation for medical research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Service de Psychiatrie II

Strasbourg, 67091, France

RECRUITING

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Central Study Contacts

Sébastien Weibel, MD

CONTACT

33 3 88 11 51 57sebastien.weibel@chru-strasbourg.fr

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 3, 2018

First Posted

July 26, 2018

Study Start

June 1, 2018

Primary Completion

June 1, 2019

Study Completion

June 1, 2019

Last Updated

July 26, 2018

Record last verified: 2018-06

Locations

FR(1)